there is a lot of negativity on this company from a couple of people.
why would people spend so much time on HC spruiking all the evils and risks of investing in HC? in my humble opinion, you must be either:
1) very bitter investors who have lost a lot of money and can't just accept the loss and all away like an investor should do with spec biotech stocks
2) down ramping as shorters.
I've got no problem with negative comments when based on industry internal mechanism knowledge re approvals etc
But to be on the thread every day talking it down is a little suss.
I've bought in relatively recently at 11.5c and accept the risk of it dropping further, but i think the CE mark would be a significant stepping stone towards commercial sales and further clinical trials, and thus raise the fair value as it is a step closer to commercial viability of the company.
if the management team are as self-serving and dishonest as you say, the company is in trouble, but I'm not convinced that some unrealistic timelines then delays = dishonesty/ corruption.
OSL Price at posting:
11.5¢ Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)